The consensus price target hints at a 26.4% upside potential for Rhythm Pharmaceuticals (RYTM). While empirical research shows that this sought-after metric is hardly effective, an upward trend in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback